Clinical Trials Logo

Clinical Trial Summary

There is a toxicity linked to the chronic use of nitrous oxide, leading to neurological disorders such as combined sclerosis of the spinal cord. One thus frequently observes patients presenting disorders of walking or paresthesias, of more or less resolving evolution being able to go until the need for using a wheelchair and more recently cases of thrombosis were reported Serum or urine N2O assays are rarely performed routinely, because they do not allow to ensure a real exposure due to the very short half-life of this gas in the body. Thus, other biological monitoring markers are mentioned in the literature, such as vitamin B12 or homocysteine. Unfortunately, there are still no recommendations for biological monitoring of nitrous oxide consumption. Moreover, underlying mechanisms leading to clinical outcomes remains misunderstood.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05540561
Study type Observational
Source University Hospital, Lille
Contact Guillaume Grzych, MD
Phone 0320445962
Email guillaume.grzych@chu-lille.fr
Status Not yet recruiting
Phase
Start date December 2022
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT04095494 - Study Of the Nitrous Oxide Perception in Health Students
Not yet recruiting NCT05714917 - Neurological Recovery Following NOS-SACD